# EDGAR Filing Document

**Accession Number:** 0002033227
**File Stem:** 0001099910-26-000170
**Filing Date:** 2026-5
**Character Count:** 28734
**Document Hash:** 54ae8ba5ad65bca11b283d9af32d70b0
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001099910-26-000170.hdr.sgml**: 20260507

**ACCESSION NUMBER**: 0001099910-26-000170

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260507

**DATE AS OF CHANGE**: 20260507

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BranchOut Food Inc.
- **CENTRAL INDEX KEY:** 0001962481
- **STANDARD INDUSTRIAL CLASSIFICATION:** FOOD & KINDRED PRODUCTS [2000]
- **ORGANIZATION NAME:** 04 Manufacturing
- **EIN:** 873980472
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94512
- **FILM NUMBER:** 26954696

**BUSINESS ADDRESS:**
- **STREET 1:** 205 SE DAVIS AVENUE,
- **STREET 2:** SUITE C
- **CITY:** BEND
- **STATE:** OR
- **ZIP:** 97702
- **BUSINESS PHONE:** 844-263-6637

**MAIL ADDRESS:**
- **STREET 1:** 205 SE DAVIS AVENUE,
- **STREET 2:** SUITE C
- **CITY:** BEND
- **STATE:** OR
- **ZIP:** 97702
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Kaufman Kapital LLC
- **CENTRAL INDEX KEY:** 0002033227

**ORGANIZATION NAME:**
- **EIN:** 994077921
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 2158 PARK BOULEVARD
- **CITY:** SAN JUAN
- **PROVINCE COUNTRY:** PR
- **BUSINESS PHONE:** 786-835-5992

**MAIL ADDRESS:**
- **ADDRESS IS A NON US LOCATION:** YES
- **STREET 1:** 2158 PARK BOULEVARD
- **CITY:** SAN JUAN
- **PROVINCE COUNTRY:** PR

## Ex-99

**Exhibit B**

**WARRANT EXERCISE AND AMENDMENT TO NOTE AND WARRANT AGREEMENT** 

THIS WARRANT EXERCISE AND AMENDMENT TO NOTE AND WARRANT AGREEMENT (this "***Agreement***"), dated as of May 7, 2026, is made by and among BranchOut Food Inc., a Nevada corporation (the "***Company***"), and Kaufman Kapital LLC ("***Kaufman Kapital***").

**RECITALS** 

**WHEREAS**, Kaufman Kapital is the holder of (i) a 12% Senior Secured Convertible Promissory Note of the Company in the original principal amount of up to $3,400,000, dated as of July 15, 2024, with a current outstanding principal balance of $2,900,000 (the "***Convertible Note***"), and (ii) a warrant to purchase 500,000 shares of the Company's common stock at an exercise price of $1.50 per share, dated July 15, 2024 (the "***$1.50 Warrant***");

**WHEREAS**, the maturity date of the Convertible Note and the expiration date of the $1.50 Warrant were each previously extended to December 31, 2026 pursuant to that certain Warrant Exercise and Amendment to Notes and Warrant Agreement, dated as of May 30, 2025, between the Company and Kaufman Kapital (the "***June 2025 Amendment***");

**WHEREAS**, the Company has requested that Kaufman Kapital exercise the $1.50 Warrant to provide the Company with working capital, and Kaufman Kapital is willing to do so, subject to the terms and conditions of this Agreement; and

**WHEREAS**, in consideration of Kaufman Kapital's exercise of the $1.50 Warrant, the Company and Kaufman Kapital desire to amend certain terms of the Convertible Note as provided herein.

**NOW, THEREFORE**, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto hereby agree as follows:

**1. Effective Time.** This Agreement shall become effective upon the Company's actual receipt of the Exercise Price (as defined in Section 3 below) by wire transfer of immediately available funds (the "***Effective Time***"). Until the Effective Time, the amendments set forth in Section 2 and the prepayment restrictions set forth in Section 4 shall have no force or effect.

&nbsp;&nbsp;&nbsp;&nbsp;**2.** **Amendments to the Convertible Note.** Effective as of the Effective Time:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) *Extension of Maturity Date.*** The definition of the "Maturity Date" as set forth in the Convertible Note is hereby amended by replacing "December 31, 2026" with "December 31, 2027."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) *Reduction of Interest Rate.*** Section 2.A. of the Convertible Note is hereby amended to replace "twelve (12%) percent" with "eight (8%) percent." For the avoidance of doubt, all interest accrued under the Convertible Note through the Effective Time shall be calculated at the rate of twelve percent (12%) per annum. From and after the Effective Time, interest shall accrue at the rate of eight percent (8%) per annum. Interest accrued at 12% prior to the Effective Time remains outstanding and convertible in accordance with the terms of the Convertible Note.

**3. Exercise of $1.50 Warrant.** Kaufman Kapital hereby irrevocably exercises the $1.50 Warrant in full on a cash basis for 500,000 shares of the Company's common stock, for an aggregate exercise price of $750,000 (the "***Exercise Price***"), to be paid to the Company by wire transfer of immediately available funds concurrently with the execution of this Agreement. The Company shall deliver the 500,000 shares of common stock to Kaufman Kapital promptly following receipt of the Exercise Price in accordance with the terms of the $1.50 Warrant.

**4. Prepayment Restrictions.** Effective as of the Effective Time, the prepayment restrictions set forth in Section 5 of the June 2025 Amendment are hereby amended and restated in their entirety as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a)** Unless otherwise agreed to by Kaufman Kapital, in no event shall the Company prepay more than $2,400,000 of principal outstanding under the Convertible Note prior to September 30, 2027.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b)** For the avoidance of doubt, the foregoing restrictions shall not limit Kaufman Kapital's right to convert outstanding principal and accrued interest under the Convertible Note into shares of common stock at any time in accordance with the terms thereof.

&nbsp;&nbsp;&nbsp;&nbsp;5. Registration of Warrant Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(a) *Filing Obligation.*** Within thirty (30) calendar days following the Effective Time, the Company shall file with the Securities and Exchange Commission (the "SEC") a new registration statement on Form S-3 (or, if the Company is not eligible to use Form S-3, on such other form as the Company is eligible to use), or a post-effective amendment to the Company's existing Registration Statement on Form S-3 (Reg. No. 333-288512), in either case covering the resale of the 500,000 shares of Common Stock issued upon exercise of the $1.50 Warrant pursuant to Section 3 of this Agreement (the "***New Registration Statement***") (the "***Warrant Shares***").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(b) *Effectiveness.*** The Company shall use commercially reasonable efforts to cause the New Registration Statement to be declared effective by the SEC as promptly as practicable following

filing, and in any event within ninety (90) calendar days following the Effective Time (or within one hundred twenty (120) calendar days if the SEC reviews and provides comments on the New Registration Statement).

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(c) *Maintenance.*** The Company shall use commercially reasonable efforts to keep the New Registration Statement continuously effective until the earliest of (i) the date on which all Warrant Shares covered by the New Registration Statement have been sold, (ii) the date on which all Warrant Shares may be sold without restriction pursuant to Rule 144 under the Securities Act of 1933, as amended, without volume or manner-of-sale limitations and without the requirement for current public information, or (iii) the second anniversary of the date on which the New Registration Statement is declared effective by the SEC.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(d) *Expenses.*** The Company shall bear all costs and expenses incurred in connection with the preparation, filing and maintenance of the New Registration Statement, including all registration and filing fees, fees and expenses of the Company's counsel and independent registered public accounting firm, and the costs of compliance with state securities or "blue sky" laws. Kaufman Kapital shall bear all underwriting discounts and commissions, if any, attributable to the sale of the Warrant Shares, and the fees and expenses of Kaufman Kapital's own counsel.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(e) *Cooperation.*** Kaufman Kapital agrees to furnish to the Company such information regarding Kaufman Kapital and the proposed distribution of the Warrant Shares as the Company may reasonably request in connection with the preparation of the New Registration Statement, including a completed selling stockholder questionnaire in customary form.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(f) *Future Registration of Interest Conversion Shares.*** At any time following the Effective Time, Kaufman Kapital shall have the right to request, by written notice to the Company, that the Company register for resale shares of common stock issuable upon conversion of accrued and unpaid interest under the Convertible Note (the "Interest Conversion Shares"). Within thirty (30) calendar days following receipt of such request, the Company shall file with the SEC a new registration statement on Form S-3 (or such other form as the Company is eligible to use), or a post-effective amendment to an existing registration statement, covering the resale of the number of Interest Conversion Shares specified in Kaufman Kapital's request. The provisions of Sections 5(b), 5(c), 5(d), and 5(e) shall apply to any such registration statement or post-effective amendment, mutatis mutandis.

**6. Public Disclosure.** The Company shall file a Current Report on Form 8-K within four (4) business days following the Effective Time disclosing the material terms of this Agreement and filing a copy of this Agreement as an exhibit thereto.

**7. No Other Amendments.** Except as expressly provided herein, the Convertible Note (including, without limitation, the conversion price, conversion mechanics, and security interest), the Securities

Purchase Agreement, the Security Agreement, and all other agreements between the parties (collectively, the "Transaction Documents") shall be unmodified and shall continue to be in full force and effect in accordance with their respective terms.

**8. Governing Law.** The laws of the State of Nevada shall govern all matters arising out of, in connection with or relating to this Agreement, including, without limitation, its validity, interpretation, construction, performance and enforcement.

**9. Counterparts.** This Agreement may be executed by the parties hereto in separate counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. Signatures delivered by electronic means (including PDF) shall be deemed original signatures.

**IN WITNESS WHEREOF**, the parties hereto have caused this Agreement to be duly executed and delivered as of the day and year first written above.

---

| | |
|:---|:---|
| **BRANCHOUT FOOD INC.** | **KAUFMAN KAPITAL LLC** |
| /s/ Eric Healy | /s/ Daniel L. Kaufman |
| By: Eric Healy | By: Daniel L. Kaufman |
| Title: Chief Executive Officer | Title: Managing Member |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 3)**

**BranchOut Food Inc.**

*(Name of Issuer)*

**Common Stock, $0.001 par value per share**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Daniel L. Kaufman**<br>2158 Park Boulevard<br>San Juan PR 00913<br>(802) 368-5885

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**05/07/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Kaufman Kapital LLC** | Name of reporting person<br>**Kaufman Kapital LLC** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**6596154.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**6596154.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6596154.00** | Aggregate amount beneficially owned by each reporting person<br>**6596154.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**33.4%** | Percent of class represented by amount in Row (11)<br>**33.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** 1  This amount includes (i) 1,903,506 shares of Common Stock held directly, (ii) 3,824,848 shares of Common Stock issuable upon conversion of $2,900,000 of outstanding principal under the Convertible Note at $0.7582 per share, and (iii) approximately 867,800 shares of Common Stock issuable upon conversion of approximately $658,100 of accrued and unpaid interest under the Convertible Note at $0.7582 per share (interest accrued at 12% through May 7, 2026 and accrues at 8% per annum thereafter). The $1.50 Warrant was exercised in full on May 7, 2026 and is no longer outstanding.

2  The percentage is calculated based upon a denominator that includes (i) 15,082,416 shares outstanding (14,582,416 per the Issuer's Annual Report on Form 10-K filed March 31, 2026, plus 500,000 shares issued upon exercise of the $1.50 Warrant on May 7, 2026) and (ii) 4,692,648 shares issuable upon conversion of derivative securities held by the Reporting Persons.

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Daniel Louis Kaufman** | Name of reporting person<br>**Daniel Louis Kaufman** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**6596154.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**6596154.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**6596154.00** | Aggregate amount beneficially owned by each reporting person<br>**6596154.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**33.4%** | Percent of class represented by amount in Row (11)<br>**33.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** 1  This amount includes (i) 1,903,506 shares of Common Stock held directly, (ii) 3,824,848 shares of Common Stock issuable upon conversion of $2,900,000 of outstanding principal under the Convertible Note at $0.7582 per share, and (iii) approximately 867,800 shares of Common Stock issuable upon conversion of approximately $658,100 of accrued and unpaid interest under the Convertible Note at $0.7582 per share (interest accrued at 12% through May 7, 2026 and accrues at 8% per annum thereafter). The $1.50 Warrant was exercised in full on May 7, 2026 and is no longer outstanding.

2  The percentage is calculated based upon a denominator that includes (i) 15,082,416 shares outstanding (14,582,416 per the Issuer's Annual Report on Form 10-K filed March 31, 2026, plus 500,000 shares issued upon exercise of the $1.50 Warrant on May 7, 2026) and (ii) 4,692,648 shares issuable upon conversion of derivative securities held by the Reporting Persons.

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, $0.001 par value per share

**(b) Name of Issuer:**
BranchOut Food Inc.

**(c) Address of Issuer's Principal Executive Offices:**
205 SE DAVIS AVENUE,, SUITE C, BEND, OR, 97702

EXPLANATORY NOTE

This Amendment No. 3 to Schedule 13D (this "Amendment") amends and supplements the Schedule 13D filed on October 17, 2024 (the "Original 13D"), as amended by Amendment No. 1 filed on December 11, 2024, and Amendment No. 2 filed on April 6, 2026 (collectively, as amended, the "Schedule 13D"), by Daniel L. Kaufman ("Kaufman") and Kaufman Kapital LLC ("Kaufman Kapital," and together with Kaufman, the "Reporting Persons") with respect to the common stock, $0.001 par value per share (the "Common Stock"), of BranchOut Food Inc., a Nevada corporation (the "Issuer").
This Amendment is being filed to report (i) the sale by Kaufman Kapital of 255,951 shares of Common Stock on May 5, 2026, (ii) the exercise by Kaufman Kapital of the $1.50 Warrant for 500,000 shares of Common Stock on May 7, 2026, (iii) the amendment of the Convertible Note and related registration rights covenant on May 7, 2026, and (iv) updates to Items 3, 4, 5 and 6 of the Schedule 13D. Except as specifically amended and supplemented hereby, the Schedule 13D remains in full force and effect.

**Item 4. Purpose of Transaction**

Item 4 of the Schedule 13D is hereby amended and restated in its entirety, and supersedes and replaces in its entirety the Item 4 disclosure in the Original 13D, Amendment No. 1, and Amendment No. 2, as follows:

May 2026 Warrant Exercise. On May 7, 2026, Kaufman Kapital exercised the $1.50 Warrant in full for 500,000 shares of Common Stock at $1.50 per share, providing $750,000 in cash to the Issuer for working capital purposes.

May 2026 Agreement. On May 7, 2026, Kaufman Kapital and the Issuer entered into a Warrant Exercise and Amendment to Note and Warrant Agreement (the "May 2026 Agreement"), pursuant to which: (i) the maturity date of the Convertible Note was extended from December 31, 2026 to December 31, 2027, (ii) the interest rate was reduced from 12% to 8% per annum (effective from the date of the May 2026 Agreement; interest accrued prior to that date was calculated at 12%), (iii) the Issuer agreed not to prepay more than $2,400,000 of principal outstanding under the Convertible Note prior to September 30, 2027 without the consent of Kaufman Kapital, and (iv) the Issuer agreed to file a registration statement or post-effective amendment covering the resale of the 500,000 Warrant Shares within thirty days, and granted Kaufman Kapital the right to request registration of shares issuable upon conversion of accrued interest under the Convertible Note at a future date. The conversion price ($0.7582 per share), conversion mechanics (conversion at the option of the holder at any time, of both principal and accrued interest), and all other terms of the Convertible Note remain unchanged.

May 2026 Stock Sales. On May 5, 2026, Kaufman Kapital sold 255,951 shares of Common Stock in open-market transactions.

Current Plans and Purposes. The Reporting Persons currently hold the securities of the Issuer for investment purposes. The Reporting Persons continuously evaluate their investment in the Issuer based on a variety of factors, including the Issuer's financial condition, results of operations, business prospects, general market and economic conditions, and other factors. Depending on such evaluation, the Reporting Persons may from time to time acquire additional securities of the Issuer (including through conversion of outstanding Convertible Note principal and accrued interest), dispose of some or all of the securities of the Issuer (including through open-market sales, privately negotiated transactions, block trades, registered offerings, or otherwise), or take any other action with respect to their investment in the Issuer as they may deem appropriate. Any such transactions may be effected at any time and from time to time, without prior notice, and will depend upon a variety of factors, including those described above.

Except as otherwise described in this Amendment, the Reporting Persons do not have any present plans or proposals that relate to or would result in any of the matters described in subparagraphs (a) through (j) of Item 4 of Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:

(a)-(b)  As of the date of this Amendment, the Reporting Persons may be deemed to beneficially own an aggregate of approximately 6,596,154 shares of Common Stock, consisting of:

**(b)**
(i)  1,903,506 shares of Common Stock held directly by Kaufman Kapital (consisting of 1,000,000 shares acquired upon exercise of the $1.00 Warrant on June 5, 2025, 659,457 shares acquired upon conversion of $500,000 of Convertible Note principal on January 28, 2026, and 500,000 shares acquired upon exercise of the $1.50 Warrant on May 7, 2026, less 255,951 shares sold in open-market transactions on May 5, 2026);

(ii)  3,824,848 shares of Common Stock issuable upon conversion of $2,900,000 of outstanding principal under the Convertible Note at the fixed conversion price of $0.7582 per share; and

(iii)  approximately 867,800 shares of Common Stock issuable upon conversion of approximately $658,100 of accrued and unpaid interest under the Convertible Note as of the date hereof, at the fixed conversion price of $0.7582 per share (interest accrues at the rate of 8% per annum on $2,900,000 of outstanding principal following the May 2026 Agreement).

The $1.50 Warrant has been exercised in full on May 7, 2026 and is no longer outstanding.

The percentage of Common Stock beneficially owned is calculated in accordance with Rule 13d-3 under the Exchange Act. The denominator includes (i) 15,082,416 shares of Common Stock outstanding (14,582,416 shares outstanding as of March 25, 2026, as reported in the Issuer's Annual Report on Form 10-K filed March 31, 2026, plus 500,000 shares issued upon exercise of the $1.50 Warrant on May 7, 2026), and (ii) an aggregate of 4,692,648 shares issuable upon conversion of derivative securities held by the Reporting Persons that are convertible within 60 days, for a total denominator of 19,775,064 shares. The Reporting Persons beneficially own approximately 33.4% of the outstanding Common Stock.

Kaufman, as the sole member and manager of Kaufman Kapital, has sole voting and dispositive power over all securities held by Kaufman Kapital. Kaufman does not directly own any shares of Common Stock.

**(c)**
The following transactions in the Common Stock were effected by the Reporting Persons during the past 60 days:

Date: May 5, 2026, Transaction: Sale of Common Stock, Shares: 255,951 (D), Price/Share: $3.2880 avg. ($3.25-$3.55)*, How Effected: Open market

Date: May 7, 2026, Transaction: Exercise of $1.50 Warrant, Shares: 500,000 (A), Price/Share: $1.50, How Effected: Warrant exercise

* Full information regarding the number of shares sold at each separate price on May 5, 2026 within the range of $3.25 to $3.55 will be provided upon request to the SEC staff, the Issuer, or a security holder of the Issuer.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

Item 6 of the Schedule 13D is hereby amended and supplemented as follows:

May 2026 Agreement. On May 7, 2026, Kaufman Kapital and the Issuer entered into the May 2026 Agreement, pursuant to which (i) the maturity date of the Convertible Note was extended from December 31, 2026 to December 31, 2027, (ii) the interest rate was reduced from 12% to 8% per annum (effective from the date of the May 2026 Agreement; interest accrued prior to that date was calculated at 12%), (iii) the Issuer agreed not to prepay more than $2,400,000 of principal outstanding under the Convertible Note prior to September 30, 2027 without the consent of Kaufman Kapital, and (iv) the Issuer agreed to file a registration statement or post-effective amendment with the SEC within thirty days covering the resale of the 500,000 shares issued upon exercise of the $1.50 Warrant, and granted Kaufman Kapital the right to request registration of shares issuable upon conversion of accrued and unpaid interest under the Convertible Note at a future date. The conversion price ($0.7582 per share), conversion mechanics, security interest, and all other material terms of the Convertible Note remain unchanged. A copy of the May 2026 Agreement is filed as Exhibit B hereto.

Warrant Exercise. The $1.50 Warrant was exercised in full on May 7, 2026 and is no longer outstanding.

The Convertible Note, as amended by the May 2026 Agreement, continues to be outstanding with a remaining principal balance of $2,900,000 and approximately $658,100 of accrued and unpaid interest as of the date hereof (calculated at 12% through the date of the May 2026 Agreement). The Convertible Note bears interest at 8% per annum (as reduced by the May 2026 Agreement), matures on December 31, 2027, and is convertible at any time at the option of the holder at a fixed conversion price of $0.7582 per share. Both outstanding principal and accrued interest are convertible into Common Stock. The Issuer may not prepay more than $2,400,000 of principal prior to September 30, 2027 without the consent of Kaufman Kapital. The Issuer's obligations under the Convertible Note continue to be secured by a lien on substantially all of the Issuer's assets pursuant to the Security Agreement.

Except as described above and in the documents previously filed with the Schedule 13D, the Reporting Persons do not have any contracts, arrangements, understandings or relationships (legal or otherwise) with any person with respect to the securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Kaufman Kapital LLC

**Signature:** Daniel L. Kaufman

**Name/Title:** Sole Member and Manager

**Date:** 05/07/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Daniel Louis Kaufman

**Signature:** Daniel Louis Kaufman

**Name/Title:** Daniel Louis Kaufman, individually

**Date:** 05/07/2026